Cannabis Report
Lithium
Home > Boards > US OTC > Biotechs > CYTODYN INC (CYDY)

I'll also add that the additional ask regarding

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
BlackDoggie Member Profile
 
Followed By 10
Posts 674
Boards Moderated 0
Alias Born 02/17/17
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 9/12/2018 4:32:34 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 9/10/2018 3:50:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/7/2018 6:26:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/7/2018 6:25:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/7/2018 6:24:14 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 9/7/2018 5:31:21 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/4/2018 4:33:16 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 8/31/2018 4:35:00 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 8/31/2018 4:33:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/28/2018 4:34:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/23/2018 7:33:49 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/14/2018 5:33:42 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/14/2018 5:32:23 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/13/2018 4:39:40 PM
Annual Report (10-k) Edgar (US Regulatory) - 7/27/2018 5:03:58 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/12/2018 4:32:55 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/27/2018 9:02:31 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/22/2018 5:02:40 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/15/2018 7:49:45 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/15/2018 7:44:52 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2018 6:04:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2018 6:03:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2018 5:59:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2018 5:59:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2018 5:57:13 PM
BlackDoggie   Friday, 11/10/17 11:37:33 AM
Re: BlackDoggie post# 18097
Post # of 28918 
I'll also add that the additional ask regarding patients for safety data may appear out of line with that reasoning at first blush. However, if I'm the FDA, and I'm agreeing to consider labeling more broadly than for a very small subset of very sick patients, I might want more safety data to justify it. Basically, if the company wants to market the drug (via the combo application) to a patient population that is less gravely ill than the patients they were originally restricted to, then the FDA might reasonably want more assurance that the drug is safe to offer to patients who may have options.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist